Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells

18 Jul 2016

Abstract excerpt

// Natalie Grinshtein 1 , Constanza C. Rioseco 1 , Richard Marcellus 2 , David Uehling 2 , Ahmed Aman 2 , Xueqing Lun 3 , Osamu Muto 1 , Lauren Podmore 1 , Jake Lever 4 , Yaoqing Shen 4 , Michael D. Blough 3 , Greg J. Cairncross 3 , Stephen M. Robbins 3 , Steven J. Jones 4, 5, 6 , Marco A. Marra 4, 5 , Rima Al-Awar 2 , Donna L. Senger 3 , David R. Kaplan 1, 7 1 Program in Neurosciences and Mental Health, The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Glioma Diagnosis and Treatment
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27449082
DOI: 10.18632/oncotarget.10661

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cellsPMID 27449082Read ↗

Advances in epigenetic glioblastoma therapySemantic proximity Read ↗

Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cellsSemantic proximity Read ↗

Epigenetic Alterations in Glioblastoma Multiforme as Novel Therapeutic Targets: A Scoping ReviewSemantic proximity Read ↗

A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem CellsSemantic proximity Read ↗

A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.Semantic proximity Read ↗

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastomaSemantic proximity Read ↗

High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of MeningiomasSemantic proximity Read ↗

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatmentSemantic proximity Read ↗

Epigenetic mechanisms of plasticity and resistance in glioblastoma: therapeutic targets and implicationsSemantic proximity Read ↗

Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insightsSemantic proximity Read ↗

Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in GlioblastomaSemantic proximity Read ↗

Chemical screens identify HDAC6 as an epigenetic vulnerability in acquired Temozolomide-resistant models of glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.